How can countries cope with more than one major respiratory virus spreading, while non- pharmaceutical interventions are being loosened week by week?

What about:

  • The possible co-circulation of influenza viruses, SARS-CoV-2, and RSV?
  • Who belongs to high risk groups?
  • Who to vaccinate and against what?
  • Guidelines and regulations for co-vaccination?
  • Forecasts on vaccine development?
  • The use of anti-virals and antibodies during different stages of the respective infections?

Each of these challenges will be addressed in our 2021 ESWI Webinar Series and conclusions, recommendations and summaries will be produced.

programme

 

Webinar:
Monday 20 September 2021 | 16:00 - 17:30 (CEST)
completed
Lecture 1
Introductory talk on Vaccination in a COVID-19 era
Sylvie van Der Werf , Institut Pasteur , France Bio
Lecture 2
Risk Groups: impact of viral infection during pregnancy on immunity of offspring
Gülsah Gabriel , Heinrich Pette Institute , Germany Bio
Lecture 3
Vaccine innovation: Developing an Ad26-based Covid vaccine
Jenny Hendriks , Janssen Vaccines & Prevention , The Netherlands Bio
Lecture 4
Equitable Vaccine Distribution
Lwazi Manzi , Head of Secretariat of the African Union Commission on COVID-19 , South Africa Bio
Lecture 5
Closing remarks and take home message
Ab Osterhaus , ESWI Chair, TiHO , Germany Bio
Webinar:
Monday 27 September 2021 | 16:00 - 17:30 (CEST)
Lecture 1
Introductory talk on Childhood Influenza Vaccination and treatment in a COVID-19 era
George Kassianos , National Immunisation Lead Royal College of General Practitioners , United Kingdom Bio
Lecture 2
The UK’s experience in Vaccinating Healthy Children - are there any benefits?
George Kassianos , National Immunisation Lead Royal College of General Practitioners , United Kingdom Bio
Lecture 3
Vaccinating children against COVID-19
Florian Krammer , Icahn School of Medicine at Mount Sinai , United States of America Bio
Lecture 4
Treating children with anti-virals for Influenza
Barbara Rath , Vienna Vaccine Safety Initiative , Germany Bio
Lecture 5
Closing remarks and take home message
Ab Osterhaus , ESWI Chair, TiHO , Germany Bio
Webinar:
Monday 4 October 2021 | 16:00 - 17:30 (CEST)
Lecture 1
Introductory talk on COVID-19 treatment and medication
Marco Goeijenbier , Erasmus MC , The Netherlands Bio
Lecture 2
Anti-viral treatment
Mike Ison , Northwestern University , United States of America
Mike Ison
Lecture 3
Immune modulatory treatment in severe COVID-19
Rik Endeman , Erasmus MC , The Netherlands
Rik Endeman
Lecture 4
Monoclonal antibodies and plasma exchange in COVID-19
To be confirmed
To be confirmed
Lecture 5
Closing remarks and take home message
Ab Osterhaus , ESWI Chair, TiHO , Germany Bio
Webinar:
Monday 11 October 2021 | 16:00 - 17:30 (CEST)

ESWI partner organisations